Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride, especially in a 1mg dose, effectively slows hair loss and improves hair growth in Japanese men with male pattern hair loss.

Low alternating doses of sodium divalproate reduced migraine frequency but caused weight gain.

High-dose mizoribine effectively controls symptoms in adolescents with lupus while reducing steroid use, with manageable side effects.

SHPro® improved urinary symptoms and erectile function in men and is safe.

Finasteride may affect fetal brain development and increase arousal, but more research is needed for safety confirmation.

Biotin supplements did not significantly reduce hair loss in rats on valproic acid.

Both finasteride and drospirenone treatments improved symptoms and increased pregnancy rates in women with polycystic ovary syndrome.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Finasteride use is strongly linked to sexual dysfunction, especially in young men treating hair loss.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

5alpha-DHP may be a safe, effective treatment for certain seizures without causing sedation.

DFMO treatment improves hair growth, muscle tone, and development in Bachmann-Bupp syndrome patients.

Using mirabegron and solifenacin together is safe and more effective for treating overactive bladder than using either drug alone.

Finasteride reduces alcohol withdrawal severity in male mice but increases it in female mice.

The enzyme 5α-reductase is key in causing psychotic-like effects from sleep deprivation.

Combination therapy of doxazosin and finasteride safely and effectively reduces benign prostatic hyperplasia progression risk.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

Using finasteride and doxazosina together works better for treating benign prostatic hyperplasia than using just one.

TTNPB helps turn stem cells into neural stem cells, improving depression-like behaviors in rats.

Topical sulfonylurea may reduce excessive hair growth caused by certain medications.

Merck will refund the cost of the drug finasteride if it doesn't improve symptoms within six months or if the patient needs surgery within two years.

Finasteride may cause depression and affect brain and gut health in male rats.

Clomipramine may significantly reduce hair-pulling in Trichotillomania, but more research is needed on treatments and early onset cases.

Three cost-effective methods accurately measure finasteride in pharmaceuticals, better than current techniques.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Two accurate methods were developed to measure finasteride in tablets.

Dutasteride and finasteride have equal safety for treating BPH without increased heart risk.

OnabotulinumtoxinA treatment improved hair-pulling disorder and hair regrowth in a woman with chronic migraines.